Providing systematic guidance in pharmacoeconomic guidelines for analysing costs

被引：0
|
作者：
Philip Jacobs
Arto Ohinmaa
Bruce Brady
机构：
[1] Institute of Health Economics,
[2] Canadian Coordinating Office for Health Technology Assessment,undefined
来源：
PharmacoEconomics | 2005年 / 23卷
关键词：
Average Cost; Excess Profit; Resource Identification; Resource Measurement; Methodological Uncertainty;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Despite the considerable amount of work that has gone into the standardisation of costs, a recent survey indicated that there is still a wide variation in methods used in costing studies in the published literature. Part of the answer to the lack of standardisation may lie in pharmacoeconomic guidelines themselves.
引用
收藏
页码：143 / 153
页数：10
相关论文
共 50 条
  • [21] GUIDELINES FOR PHARMACOECONOMIC STUDIES - THE WAYS FORWARD
    DRUMMOND, MF
    PHARMACOECONOMICS, 1994, 6 (06) : 493 - 497
  • [22] A framework for costing recommendations in pharmacoeconomic guidelines
    Jacobs, P
    Brady, BK
    VALUE IN HEALTH, 2004, 7 (03) : 225 - 225
  • [23] GUIDELINES FOR SYSTEMATIC SELECTION, EVALUATION, AND USE OF SIMULATED GUIDANCE MATERIALS
    WEINRACH, S
    PERSONNEL AND GUIDANCE JOURNAL, 1978, 56 (05): : 288 - 292
  • [24] NEED AND IMPORTANCE OF PHARMACOECONOMIC GUIDELINES IN INDIA
    Udupa, D. N.
    Janodia, M.
    Muragundi, P. M.
    VALUE IN HEALTH, 2012, 15 (04) : A32 - A32
  • [25] A case for the adoption of pharmacoeconomic guidelines in Japan
    Ikeda, S
    Ikegami, N
    Oliver, AJ
    Ikeda, M
    PHARMACOECONOMICS, 1996, 10 (06) : 546 - 551
  • [26] The costs of urinary tract infection therapy with implementation of pharmacoeconomic guidelines at the Clinic for Infectious Diseases of the Clinical Center of Vojvodina
    Stefan-Mikic, Sandra
    Sevic, Sinisa
    Doder, Radoslava
    Cvjetkovic, Dejan
    Jovanovic, Natasa
    Ruzic, Maja
    VOJNOSANITETSKI PREGLED, 2012, 69 (08) : 647 - 655
  • [27] GUIDANCE ON GUIDELINES
    LITTLEJOHNS, P
    COLLIER, J
    HILTON, S
    BRITISH MEDICAL JOURNAL, 1992, 305 (6861): : 1098 - 1098
  • [28] Perspective, costs, outcomes and discounting in pharmacoeconomic evaluations
    Brouwer, Werner B. F.
    EJHP PRACTICE, 2008, 14 (03): : 20 - 22
  • [29] Guidance for guidelines
    Steinbrook, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 331 - 333
  • [30] The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis
    Douglas Coyle
    Karen M. Lee
    PharmacoEconomics, 1998, 14 : 357 - 363
12345